Filing Details

Accession Number:
0000899243-21-007774
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-23 14:19:28
Reporting Period:
2021-02-21
Accepted Time:
2021-02-23 14:19:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO Surgical & Medical Instruments & Apparatus (3841) 204827488
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1730056 M John Sprague 101 Hartwell Avenue
Lexington MA 02421
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-21 10,000 $0.00 40,735 No 4 M Direct
Common Stock Disposition 2021-02-23 5,250 $2.04 35,485 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-02-21 10,000 $0.00 10,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. Includes 6,812 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on May 15, 2020 and 1,701 shares acquired under the ESPP on November 15, 2020.
  3. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  4. On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.